Xencor (NASDAQ:XNCR)

CAPS Rating: 5 out of 5

Caps

How do you think XNCR will perform against the market?

Add Stock to CAPS Watchlist

All Players

45 Outperform
1 Underperform
 

All-Star Players

13 Outperform
0 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top XNCR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.84)
Submitted January 31, 2015

When I first added Xencor to my database nine months ago I liked the company's proprietary platform of genetically engineered antibodies optimized for better binding to effector cells via the Fc domain. It seemed like there was a lot of potential for… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

XNCR VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about XNCR.

Recs

0
Member Avatar TMFTypeoh (93.07) Submitted: 4/3/2018 4:51:13 PM : Outperform Start Price: $28.41 XNCR Score: +31.03

How have I not green thumbed this stock already? Interesting drug development platform and partnerships galore. Cash heavy balance sheet and low burn rate. Lots to like here.

Recs

0
Member Avatar sullyz0r (57.57) Submitted: 2/1/2015 11:23:46 AM : Outperform Start Price: $15.15 XNCR Score: +119.38

Strange decline after great news. I expect an SEC filing that some big VC took the good news to get out--fine by me. Antibody therapeutics are already huge and are going to be enormous. Making the antibodies better (which is what this company does) is going to have huge implications, and all the big pharmas and their brothers will want to partner with XNCR.

Recs

0
Member Avatar line70day (< 20) Submitted: 7/11/2014 12:33:56 PM : Outperform Start Price: $9.71 XNCR Score: +259.00

XNCR First Q. Cash balance totaled $72.5 M compared to $78.0 M Dec. 31,2012 rev.for first Q. 2014 were s2.2 M compared to $ l.3 M same Qlast yr. NET LOSS FIRSTQ ENDING March 31, 2014 was $3.7M on a fully diluted per shares bases to a net loss of $4.6 Mon fullydiluted per share basis for same period in 1213 decresereflects increased revenue and lower expences in first Q. 2014 compared to Q 2013 decrease reflects outstanding asa result of their IPO inDec 2013

Leaderboard

Find the members with the highest scoring picks in XNCR.

Score Leader

cthomasset

cthomasset (74.98) Score: +337.75

The Score Leader is the player with the highest score across all their picks in XNCR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
cthomasset 74.98 12/9/2013 Outperform 5Y $7.89 +384.03% +46.28% +337.75 0 Comment
EvilEmpire 30.19 5/21/2014 Outperform 5Y $8.25 +363.13% +41.13% +322.01 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. TerryFool < 20 2/14/2014 Outperform 5Y $8.89 +329.58% +44.26% +285.33 1 Comment
line70day < 20 7/30/2014 Outperform NS $9.71 +293.31% +34.31% +259.00 1 Comment
TerryHoodSr 56.44 1/3/2014 Outperform 5Y $9.50 +302.00% +44.89% +257.11 1 Comment
Adepool 91.39 10/6/2014 Outperform 5Y $9.76 +291.29% +34.52% +256.77 0 Comment
mpappa 70.16 8/25/2014 Outperform 3Y $9.83 +288.50% +32.64% +255.87 0 Comment
All5Stars 25.78 9/11/2014 Outperform 5Y $10.64 +258.93% +33.22% +225.71 0 Comment
scrypted < 20 9/2/2014 Outperform 5Y $10.74 +255.59% +32.09% +223.50 0 Comment
portefeuille 98.42 4/4/2014 Outperform 5Y $10.87 +251.33% +42.38% +208.95 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCreditSuiss 88.73 1/3/2014 Outperform NS $9.50 +302.00% +44.89% +257.11 0 Comment

Advertisement